Loading...

Brooks David

Title(s)Assistant Professor, Microbiology Immunology & Molecular Genetics
Phone310-267-2774
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Restoring antibody effector function during persistent virus infection
    NIH/NIAID R21AI109627Jul 1, 2014 - Aug 31, 2016
    Role: Principal Investigator
    Mechanisms of Viral Persistence
    NIH/NIAID R01AI085043Dec 1, 2009 - Jan 31, 2020
    Role: Principal Investigator
    Immune Regulation of Viral Persistence and Clearance
    NIH/NIAID U01AI082975May 1, 2009 - Apr 30, 2014
    Role: Principal Investigator
    Novel Molecules that Define Viral Persistence
    NIH/NIAID R21AI077012Aug 15, 2007 - Aug 31, 2010
    Role: Principal Investigator
    CATARACTOGENESIS IN HYPERFERRITINEMIA CATARACT SYNDROME
    NIH/NEI K08EY000419Sep 1, 2000 - Aug 31, 2004
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Halaby MJ, Hezaveh K, Lamorte S, Ciudad MT, Kloetgen A, MacLeod BL, Guo M, Chakravarthy A, Medina TDS, Ugel S, Tsirigos A, Bronte V, Munn DH, Pugh TJ, De Carvalho DD, Butler MO, Ohashi PS, Brooks DG, McGaha TL. GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironment. Sci Immunol. 2019 Dec 13; 4(42). PMID: 31836669.
      View in: PubMed
    2. Lukhele S, Boukhaled GM, Brooks DG. Type I interferon signaling, regulation and gene stimulation in chronic virus infection. Semin Immunol. 2019 Jun; 43:101277. PMID: 31155227.
      View in: PubMed
    3. Woo JS, Srikanth S, Kim KD, Elsaesser H, Lu J, Pellegrini M, Brooks DG, Sun Z, Gwack Y. Correction: CRACR2A-Mediated TCR Signaling Promotes Local Effector Th1 and Th17 Responses. J Immunol. 2019 Jul 01; 203(1):293. PMID: 31127031.
      View in: PubMed
    4. Gadalla R, Noamani B, MacLeod BL, Dickson RJ, Guo M, Xu W, Lukhele S, Elsaesser HJ, Razak ARA, Hirano N, McGaha TL, Wang B, Butler M, Guidos CJ, Ohashi PS, Siu LL, Brooks DG. Validation of CyTOF Against Flow Cytometry for Immunological Studies and Monitoring of Human Cancer Clinical Trials. Front Oncol. 2019; 9:415. PMID: 31165047.
      View in: PubMed
    5. Palchevskiy V, Xue YY, Kern R, Weigt SS, Gregson AL, Song SX, Fishbein MC, Hogaboam CM, Sayah DM, Lynch JP, Keane MP, Brooks DG, Belperio JA. CCR4 expression on host T cells is a driver for alloreactive responses and lung rejection. JCI Insight. 2019 May 14; 5. PMID: 31085832.
      View in: PubMed
    6. Rojas OL, Pröbstel AK, Porfilio EA, Wang AA, Charabati M, Sun T, Lee DSW, Galicia G, Ramaglia V, Ward LA, Leung LYT, Najafi G, Khaleghi K, Garcillán B, Li A, Besla R, Naouar I, Cao EY, Chiaranunt P, Burrows K, Robinson HG, Allanach JR, Yam J, Luck H, Campbell DJ, Allman D, Brooks DG, Tomura M, Baumann R, Zamvil SS, Bar-Or A, Horwitz MS, Winer DA, Mortha A, Mackay F, Prat A, Osborne LC, Robbins C, Baranzini SE, Gommerman JL. Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10. Cell. 2019 Apr 04; 177(2):492-493. PMID: 30951673.
      View in: PubMed
    7. Clouthier DL, Lien SC, Yang SYC, Nguyen LT, Manem VSK, Gray D, Ryczko M, Razak ARA, Lewin J, Lheureux S, Colombo I, Bedard PL, Cescon D, Spreafico A, Butler MO, Hansen AR, Jang RW, Ghai S, Weinreb I, Sotov V, Gadalla R, Noamani B, Guo M, Elston S, Giesler A, Hakgor S, Jiang H, McGaha T, Brooks DG, Haibe-Kains B, Pugh TJ, Ohashi PS, Siu LL. An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE). J Immunother Cancer. 2019 Mar 13; 7(1):72. PMID: 30867072.
      View in: PubMed
    8. Rojas OL, Pröbstel AK, Porfilio EA, Wang AA, Charabati M, Sun T, Lee DSW, Galicia G, Ramaglia V, Ward LA, Leung LYT, Najafi G, Khaleghi K, Garcillán B, Li A, Besla R, Naouar I, Cao EY, Chiaranunt P, Burrows K, Robinson HG, Allanach JR, Yam J, Luck H, Campbell DJ, Allman D, Brooks DG, Tomura M, Baumann R, Zamvil SS, Bar-Or A, Horwitz MS, Winer DA, Mortha A, Mackay F, Prat A, Osborne LC, Robbins C, Baranzini SE, Gommerman JL. Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10. Cell. 2019 01 24; 176(3):610-624.e18. PMID: 30612739.
      View in: PubMed
    9. Snell LM, MacLeod BL, Law JC, Osokine I, Elsaesser HJ, Hezaveh K, Dickson RJ, Gavin MA, Guidos CJ, McGaha TL, Brooks DG. CD8+ T Cell Priming in Established Chronic Viral Infection Preferentially Directs Differentiation of Memory-like Cells for Sustained Immunity. Immunity. 2018 10 16; 49(4):678-694.e5. PMID: 30314757.
      View in: PubMed
    10. Woo JS, Srikanth S, Kim KD, Elsaesser H, Lu J, Pellegrini M, Brooks DG, Sun Z, Gwack Y. CRACR2A-Mediated TCR Signaling Promotes Local Effector Th1 and Th17 Responses. J Immunol. 2018 08 15; 201(4):1174-1185. PMID: 29987160.
      View in: PubMed
    11. Clemente-Casares X, Hosseinzadeh S, Barbu I, Dick SA, Macklin JA, Wang Y, Momen A, Kantores C, Aronoff L, Farno M, Lucas TM, Avery J, Zarrin-Khat D, Elsaesser HJ, Razani B, Lavine KJ, Husain M, Brooks DG, Robbins CS, Cybulsky M, Epelman S. A CD103+ Conventional Dendritic Cell Surveillance System Prevents Development of Overt Heart Failure during Subclinical Viral Myocarditis. Immunity. 2017 11 21; 47(5):974-989.e8. PMID: 29166591.
      View in: PubMed
    12. Chan J, Kim PY, Kranz E, Nagaoka Y, Lee Y, Wen J, Elsaesser HJ, Qin M, Brooks DG, Ringpis GE, Chen ISY, Kamata M. Purging Exhausted Virus-Specific CD8 T Cell Phenotypes by Somatic Cell Reprogramming. AIDS Res Hum Retroviruses. 2017 Nov; 33(S1):S59-S69. PMID: 29140111.
      View in: PubMed
    13. Snell LM, McGaha TL, Brooks DG. Type I Interferon in Chronic Virus Infection and Cancer. Trends Immunol. 2017 08; 38(8):542-557. PMID: 28579323.
      View in: PubMed
    14. Zhen A, Rezek V, Youn C, Lam B, Chang N, Rick J, Carrillo M, Martin H, Kasparian S, Syed P, Rice N, Brooks DG, Kitchen SG. Targeting type I interferon-mediated activation restores immune function in chronic HIV infection. J Clin Invest. 2017 01 03; 127(1):260-268. PMID: 27941243.
      View in: PubMed
    15. Snell LM, Osokine I, Yamada DH, De la Fuente JR, Elsaesser HJ, Brooks DG. Overcoming CD4 Th1 Cell Fate Restrictions to Sustain Antiviral CD8 T Cells and Control Persistent Virus Infection. Cell Rep. 2016 09 20; 16(12):3286-3296. PMID: 27653690.
      View in: PubMed
    16. Cunningham CR, Champhekar A, Tullius MV, Dillon BJ, Zhen A, de la Fuente JR, Herskovitz J, Elsaesser H, Snell LM, Wilson EB, de la Torre JC, Kitchen SG, Horwitz MA, Bensinger SJ, Smale ST, Brooks DG. Type I and Type II Interferon Coordinately Regulate Suppressive Dendritic Cell Fate and Function during Viral Persistence. PLoS Pathog. 2016 Jan; 12(1):e1005356. PMID: 26808628.
      View in: PubMed
    17. York AG, Williams KJ, Argus JP, Zhou QD, Brar G, Vergnes L, Gray EE, Zhen A, Wu NC, Yamada DH, Cunningham CR, Tarling EJ, Wilks MQ, Casero D, Gray DH, Yu AK, Wang ES, Brooks DG, Sun R, Kitchen SG, Wu TT, Reue K, Stetson DB, Bensinger SJ. Limiting Cholesterol Biosynthetic Flux Spontaneously Engages Type I IFN Signaling. Cell. 2015 Dec 17; 163(7):1716-29. PMID: 26686653.
      View in: PubMed
    18. Walsh NC, Waters LR, Fowler JA, Lin M, Cunningham CR, Brooks DG, Rehg JE, Morse HC, Teitell MA. LKB1 inhibition of NF-?B in B cells prevents T follicular helper cell differentiation and germinal center formation. EMBO Rep. 2015 Jun; 16(6):753-68. PMID: 25916856.
      View in: PubMed
    19. Snell LM, Brooks DG. New insights into type I interferon and the immunopathogenesis of persistent viral infections. Curr Opin Immunol. 2015 Jun; 34:91-8. PMID: 25771184.
      View in: PubMed
    20. Yamada DH, Elsaesser H, Lux A, Timmerman JM, Morrison SL, de la Torre JC, Nimmerjahn F, Brooks DG. Suppression of Fc?-receptor-mediated antibody effector function during persistent viral infection. Immunity. 2015 Feb 17; 42(2):379-390. PMID: 25680277.
      View in: PubMed
    21. Boyle DS, McNerney R, Teng Low H, Leader BT, Pérez-Osorio AC, Meyer JC, O'Sullivan DM, Brooks DG, Piepenburg O, Forrest MS. Rapid detection of Mycobacterium tuberculosis by recombinase polymerase amplification. PLoS One. 2014; 9(8):e103091. PMID: 25118698.
      View in: PubMed
    22. Wilson EB, Brooks DG. Decoding the complexity of type I interferon to treat persistent viral infections. Trends Microbiol. 2013 Dec; 21(12):634-40. PMID: 24216022.
      View in: PubMed
    23. Gillespie EJ, Ho CL, Balaji K, Clemens DL, Deng G, Wang YE, Elsaesser HJ, Tamilselvam B, Gargi A, Dixon SD, France B, Chamberlain BT, Blanke SR, Cheng G, de la Torre JC, Brooks DG, Jung ME, Colicelli J, Damoiseaux R, Bradley KA. Selective inhibitor of endosomal trafficking pathways exploited by multiple toxins and viruses. Proc Natl Acad Sci U S A. 2013 Dec 10; 110(50):E4904-12. PMID: 24191014.
      View in: PubMed
    24. Martell RE, Brooks DG, Wang Y, Wilcoxen K. Discovery of novel drugs for promising targets. Clin Ther. 2013 Sep; 35(9):1271-81. PMID: 24054704.
      View in: PubMed
    25. Wilson EB, Brooks DG. Interfering with type I interferon: a novel approach to purge persistent viral infection. Cell Cycle. 2013 Sep 15; 12(18):2919-20. PMID: 23974094.
      View in: PubMed
    26. Ng CT, Snell LM, Brooks DG, Oldstone MB. Networking at the level of host immunity: immune cell interactions during persistent viral infections. Cell Host Microbe. 2013 Jun 12; 13(6):652-64. PMID: 23768490.
      View in: PubMed
    27. Wilson EB, Yamada DH, Elsaesser H, Herskovitz J, Deng J, Cheng G, Aronow BJ, Karp CL, Brooks DG. Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science. 2013 Apr 12; 340(6129):202-7. PMID: 23580528.
      View in: PubMed
    28. Kidani Y, Elsaesser H, Hock MB, Vergnes L, Williams KJ, Argus JP, Marbois BN, Komisopoulou E, Wilson EB, Osborne TF, Graeber TG, Reue K, Brooks DG, Bensinger SJ. Sterol regulatory element-binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity. Nat Immunol. 2013 May; 14(5):489-99. PMID: 23563690.
      View in: PubMed
    29. Wilson EB, Brooks DG. Inflammation makes T cells sensitive. Immunity. 2013 Jan 24; 38(1):5-7. PMID: 23352218.
      View in: PubMed
    30. Canestaro WJ, Brooks DG, Chaplin D, Choudhry NK, Lawler E, Martell L, Brennan T, Wassman ER. Statin pharmacogenomics: opportunities to improve patient outcomes and healthcare costs with genetic testing. J Pers Med. 2012 Oct 17; 2(4):158-74. PMID: 25562358.
      View in: PubMed
    31. Wilson EB, Kidani Y, Elsaesser H, Barnard J, Raff L, Karp CL, Bensinger S, Brooks DG. Emergence of distinct multiarmed immunoregulatory antigen-presenting cells during persistent viral infection. Cell Host Microbe. 2012 May 17; 11(5):481-91. PMID: 22607801.
      View in: PubMed
    32. Tomassian T, Humphries LA, Liu SD, Silva O, Brooks DG, Miceli MC. Caveolin-1 orchestrates TCR synaptic polarity, signal specificity, and function in CD8 T cells. J Immunol. 2011 Sep 15; 187(6):2993-3002. PMID: 21849673.
      View in: PubMed
    33. Fahey LM, Wilson EB, Elsaesser H, Fistonich CD, McGavern DB, Brooks DG. Viral persistence redirects CD4 T cell differentiation toward T follicular helper cells. J Exp Med. 2011 May 09; 208(5):987-99. PMID: 21536743.
      View in: PubMed
    34. Wilson EB, Brooks DG. The role of IL-10 in regulating immunity to persistent viral infections. Curr Top Microbiol Immunol. 2011; 350:39-65. PMID: 20703965.
      View in: PubMed
    35. Wilson EB, Brooks DG. Translating insights from persistent LCMV infection into anti-HIV immunity. Immunol Res. 2010 Dec; 48(1-3):3-13. PMID: 20725865.
      View in: PubMed
    36. Fahey LM, Brooks DG. Opposing positive and negative regulation of T cell activity during viral persistence. Curr Opin Immunol. 2010 Jun; 22(3):348-54. PMID: 20381328.
      View in: PubMed
    37. Brooks DG, Walsh KB, Elsaesser H, Oldstone MB. IL-10 directly suppresses CD4 but not CD8 T cell effector and memory responses following acute viral infection. Proc Natl Acad Sci U S A. 2010 Feb 16; 107(7):3018-23. PMID: 20133700.
      View in: PubMed
    38. Luo F, Brooks DG, Ye H, Hamoudi R, Poulogiannis G, Patek CE, Winton DJ, Arends MJ. Mutated K-ras(Asp12) promotes tumourigenesis in Apc(Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways. Int J Exp Pathol. 2009 Oct; 90(5):558-74. PMID: 19765110.
      View in: PubMed
    39. Brooks DG. Suppressing the suppressor. Blood. 2009 Jul 09; 114(2):233. PMID: 19589930.
      View in: PubMed
    40. Garidou L, Heydari S, Truong P, Brooks DG, McGavern DB. Therapeutic memory T cells require costimulation for effective clearance of a persistent viral infection. J Virol. 2009 Sep; 83(17):8905-15. PMID: 19553326.
      View in: PubMed
    41. Elsaesser H, Sauer K, Brooks DG. IL-21 is required to control chronic viral infection. Science. 2009 Jun 19; 324(5934):1569-72. PMID: 19423777.
      View in: PubMed
    42. Brooks DG, Ha SJ, Elsaesser H, Sharpe AH, Freeman GJ, Oldstone MB. IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection. Proc Natl Acad Sci U S A. 2008 Dec 23; 105(51):20428-33. PMID: 19075244.
      View in: PubMed
    43. Gonzalvez F, Schug ZT, Houtkooper RH, MacKenzie ED, Brooks DG, Wanders RJ, Petit PX, Vaz FM, Gottlieb E. Cardiolipin provides an essential activating platform for caspase-8 on mitochondria. J Cell Biol. 2008 Nov 17; 183(4):681-96. PMID: 19001123.
      View in: PubMed
    44. Brooks DG, Lee AM, Elsaesser H, McGavern DB, Oldstone MB. IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection. J Exp Med. 2008 Mar 17; 205(3):533-41. PMID: 18332180.
      View in: PubMed
    45. Syed SP, Brooks DG, Haupt HM, Bellucci K, Martin AM, Podolski V, Brooks JJ. Anabolic steroids causing growth of benign tumors: androgen receptor in angiolipomas. J Am Acad Dermatol. 2007 Nov; 57(5):899-900. PMID: 17939941.
      View in: PubMed
    46. Luo F, Hamoudi R, Brooks DG, Patek CE, Arends MJ. Stem cell gene expression changes induced specifically by mutated K-ras. Gene Expr. 2007; 14(2):101-15. PMID: 18257393.
      View in: PubMed
    47. Stewart DR, Corless CL, Rubin BP, Heinrich MC, Messiaen LM, Kessler LJ, Zhang PJ, Brooks DG. Mitotic recombination as evidence of alternative pathogenesis of gastrointestinal stromal tumours in neurofibromatosis type 1. J Med Genet. 2007 Jan; 44(1):e61. PMID: 17209131.
      View in: PubMed
    48. Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB, Oldstone MB. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med. 2006 Nov; 12(11):1301-9. PMID: 17041596.
      View in: PubMed
    49. Bateman JB, Richter L, Flodman P, Burch D, Brown S, Penrose P, Paul O, Geyer DD, Brooks DG, Spence MA. A new locus for autosomal dominant cataract on chromosome 19: linkage analyses and screening of candidate genes. Invest Ophthalmol Vis Sci. 2006 Aug; 47(8):3441-9. PMID: 16877414.
      View in: PubMed
    50. Brooks DG, McGavern DB, Oldstone MB. Reprogramming of antiviral T cells prevents inactivation and restores T cell activity during persistent viral infection. J Clin Invest. 2006 Jun; 116(6):1675-85. PMID: 16710479.
      View in: PubMed
    51. Tao R, Jin B, Guo SZ, Qing W, Feng GY, Brooks DG, Liu L, Xu J, Li T, Yan Y, He L. A novel missense mutation of the EDA gene in a Mongolian family with congenital hypodontia. J Hum Genet. 2006; 51(5):498-502. PMID: 16583127.
      View in: PubMed
    52. Arlen PA, Brooks DG, Gao LY, Vatakis D, Brown HJ, Zack JA. Rapid expression of human immunodeficiency virus following activation of latently infected cells. J Virol. 2006 Feb; 80(3):1599-603. PMID: 16415036.
      View in: PubMed
    53. Brooks DG, Cohen MD, Jamieson BD, Poon B, Kitchen SG, Chow SA, Chen IS, Zack JA, Koka PS. Rapid size dependent deletion of foreign gene sequences inserted into attenuated HIV-1 upon infection in vivo: implications for vaccine development. Curr HIV Res. 2005 Oct; 3(4):377-92. PMID: 16250884.
      View in: PubMed
    54. Brooks DG, Teyton L, Oldstone MB, McGavern DB. Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection. J Virol. 2005 Aug; 79(16):10514-27. PMID: 16051844.
      View in: PubMed
    55. Lobmayr L, Brooks DG, Wilson RB. Increased IRP1 activity in Friedreich ataxia. Gene. 2005 Jul 18; 354:157-61. PMID: 15970401.
      View in: PubMed
    56. Dunaief JL, Richa C, Franks EP, Schultze RL, Aleman TS, Schenck JF, Zimmerman EA, Brooks DG. Macular degeneration in a patient with aceruloplasminemia, a disease associated with retinal iron overload. Ophthalmology. 2005 Jun; 112(6):1062-5. PMID: 15882908.
      View in: PubMed
    57. Kitchen SG, Jones NR, LaForge S, Whitmire JK, Vu BA, Galic Z, Brooks DG, Brown SJ, Kitchen CM, Zack JA. CD4 on CD8(+) T cells directly enhances effector function and is a target for HIV infection. Proc Natl Acad Sci U S A. 2004 Jun 08; 101(23):8727-32. PMID: 15173593.
      View in: PubMed
    58. King A, Gottlieb E, Brooks DG, Murphy MP, Dunaief JL. Mitochondria-derived reactive oxygen species mediate blue light-induced death of retinal pigment epithelial cells. Photochem Photobiol. 2004 May; 79(5):470-5. PMID: 15191057.
      View in: PubMed
    59. Brooks DG. The neurofibromatoses: hereditary predisposition to multiple peripheral nerve tumors. Neurosurg Clin N Am. 2004 Apr; 15(2):145-55. PMID: 15177314.
      View in: PubMed
    60. Ali A, Lubong R, Ng H, Brooks DG, Zack JA, Yang OO. Impacts of epitope expression kinetics and class I downregulation on the antiviral activity of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes. J Virol. 2004 Jan; 78(2):561-7. PMID: 14694087.
      View in: PubMed
    61. Kantor J, Kessler LJ, Brooks DG, Cotsarelis G. Decreased serum ferritin is associated with alopecia in women. J Invest Dermatol. 2003 Nov; 121(5):985-8. PMID: 14708596.
      View in: PubMed
    62. Brooks DG, Arlen PA, Gao L, Kitchen CM, Zack JA. Identification of T cell-signaling pathways that stimulate latent HIV in primary cells. Proc Natl Acad Sci U S A. 2003 Oct 28; 100(22):12955-60. PMID: 14569007.
      View in: PubMed
    63. James RM, Arends MJ, Plowman SJ, Brooks DG, Miles CG, West JD, Patek CE. K-ras proto-oncogene exhibits tumor suppressor activity as its absence promotes tumorigenesis in murine teratomas. Mol Cancer Res. 2003 Sep; 1(11):820-5. PMID: 14517344.
      View in: PubMed
    64. Brooks DG, Hamer DH, Arlen PA, Gao L, Bristol G, Kitchen CM, Berger EA, Zack JA. Molecular characterization, reactivation, and depletion of latent HIV. Immunity. 2003 Sep; 19(3):413-23. PMID: 14499116.
      View in: PubMed
    65. Koka PS, Brooks DG, Razai A, Kitchen CM, Zack JA. HIV type 1 infection alters cytokine mRNA expression in thymus. AIDS Res Hum Retroviruses. 2003 Jan 01; 19(1):1-12. PMID: 12581511.
      View in: PubMed
    66. Scripture-Adams DD, Brooks DG, Korin YD, Zack JA. Interleukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype. J Virol. 2002 Dec; 76(24):13077-82. PMID: 12438635.
      View in: PubMed
    67. Korin YD, Brooks DG, Brown S, Korotzer A, Zack JA. Effects of prostratin on T-cell activation and human immunodeficiency virus latency. J Virol. 2002 Aug; 76(16):8118-23. PMID: 12134017.
      View in: PubMed
    68. Brooks DG. The first genetic locus mapped for RLS is unlikely to be the last. Article reviewed: 'Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q'. Sleep Med. 2002 May; 3(3):285-6. PMID: 14592222.
      View in: PubMed
    69. Brooks DG, Manova-Todorova K, Farmer J, Lobmayr L, Wilson RB, Eagle RC, St Pierre TG, Stambolian D. Ferritin crystal cataracts in hereditary hyperferritinemia cataract syndrome. Invest Ophthalmol Vis Sci. 2002 Apr; 43(4):1121-6. PMID: 11923255.
      View in: PubMed
    70. Brooks DG, Zack JA. Effect of latent human immunodeficiency virus infection on cell surface phenotype. J Virol. 2002 Feb; 76(4):1673-81. PMID: 11799162.
      View in: PubMed